227 related articles for article (PubMed ID: 15596686)
1. Decline in lung function in patients with lymphangioleiomyomatosis treated with or without progesterone.
Taveira-DaSilva AM; Stylianou MP; Hedin CJ; Hathaway O; Moss J
Chest; 2004 Dec; 126(6):1867-74. PubMed ID: 15596686
[TBL] [Abstract][Full Text] [Related]
2. Bone mineral density in lymphangioleiomyomatosis.
Taveira-Dasilva AM; Stylianou MP; Hedin CJ; Hathaway O; Moss J
Am J Respir Crit Care Med; 2005 Jan; 171(1):61-7. PubMed ID: 15466255
[TBL] [Abstract][Full Text] [Related]
3. A prospective study of pulmonary function in patients treated with paclitaxel and carboplatin.
Dimopoulou I; Galani H; Dafni U; Samakovii A; Roussos C; Dimopoulos MA
Cancer; 2002 Jan; 94(2):452-8. PubMed ID: 11900231
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor-D is increased in serum of patients with lymphangioleiomyomatosis.
Seyama K; Kumasaka T; Souma S; Sato T; Kurihara M; Mitani K; Tominaga S; Fukuchi Y
Lymphat Res Biol; 2006; 4(3):143-52. PubMed ID: 17034294
[TBL] [Abstract][Full Text] [Related]
5. Sustained effects of sirolimus on lung function and cystic lung lesions in lymphangioleiomyomatosis.
Yao J; Taveira-DaSilva AM; Jones AM; Julien-Williams P; Stylianou M; Moss J
Am J Respir Crit Care Med; 2014 Dec; 190(11):1273-82. PubMed ID: 25329516
[TBL] [Abstract][Full Text] [Related]
6. Different diffusing capacity of the lung for carbon monoxide as predictors of respiratory morbidity.
Cerfolio RJ; Bryant AS
Ann Thorac Surg; 2009 Aug; 88(2):405-10; discussion 410-1. PubMed ID: 19632384
[TBL] [Abstract][Full Text] [Related]
7. Lymphangioleiomyomatosis: correlation of qualitative and quantitative thin-section CT with pulmonary function tests and assessment of dependence on pleurodesis.
Avila NA; Kelly JA; Dwyer AJ; Johnson DL; Jones EC; Moss J
Radiology; 2002 Apr; 223(1):189-97. PubMed ID: 11930066
[TBL] [Abstract][Full Text] [Related]
8. Decline in lung function in lymphangioleiomyomatosis: relation to menopause and progesterone treatment.
Johnson SR; Tattersfield AE
Am J Respir Crit Care Med; 1999 Aug; 160(2):628-33. PubMed ID: 10430739
[TBL] [Abstract][Full Text] [Related]
9. Reversible airflow obstruction in lymphangioleiomyomatosis.
Taveira-DaSilva AM; Steagall WK; Rabel A; Hathaway O; Harari S; Cassandro R; Stylianou M; Moss J
Chest; 2009 Dec; 136(6):1596-1603. PubMed ID: 19447921
[TBL] [Abstract][Full Text] [Related]
10. Automated algorithm for quantifying the extent of cystic change on volumetric chest CT: initial results in Lymphangioleiomyomatosis.
Schmithorst VJ; Altes TA; Young LR; Franz DN; Bissler JJ; McCormack FX; Dardzinski BJ; Brody AS
AJR Am J Roentgenol; 2009 Apr; 192(4):1037-44. PubMed ID: 19304711
[TBL] [Abstract][Full Text] [Related]
11. Changes in lung function and chylous effusions in patients with lymphangioleiomyomatosis treated with sirolimus.
Taveira-DaSilva AM; Hathaway O; Stylianou M; Moss J
Ann Intern Med; 2011 Jun; 154(12):797-805, W-292-3. PubMed ID: 21690594
[TBL] [Abstract][Full Text] [Related]
12. Long-Term Effect of Sirolimus on Serum Vascular Endothelial Growth Factor D Levels in Patients With Lymphangioleiomyomatosis.
Taveira-DaSilva AM; Jones AM; Julien-Williams P; Stylianou M; Moss J
Chest; 2018 Jan; 153(1):124-132. PubMed ID: 28533049
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of low-dose Sirolimus in Lymphangioleiomyomatosis.
Yoon HY; Hwang JJ; Kim DS; Song JW
Orphanet J Rare Dis; 2018 Nov; 13(1):204. PubMed ID: 30428897
[TBL] [Abstract][Full Text] [Related]
14. Effect of lung resection on exercise capacity and on carbon monoxide diffusing capacity during exercise.
Wang JS; Abboud RT; Wang LM
Chest; 2006 Apr; 129(4):863-72. PubMed ID: 16608931
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary lymphangioleiomyomatosis. A study of 69 patients. Groupe d'Etudes et de Recherche sur les Maladies "Orphelines" Pulmonaires (GERM"O"P).
Urban T; Lazor R; Lacronique J; Murris M; Labrune S; Valeyre D; Cordier JF
Medicine (Baltimore); 1999 Sep; 78(5):321-37. PubMed ID: 10499073
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of sirolimus in lymphangioleiomyomatosis.
McCormack FX; Inoue Y; Moss J; Singer LG; Strange C; Nakata K; Barker AF; Chapman JT; Brantly ML; Stocks JM; Brown KK; Lynch JP; Goldberg HJ; Young LR; Kinder BW; Downey GP; Sullivan EJ; Colby TV; McKay RT; Cohen MM; Korbee L; Taveira-DaSilva AM; Lee HS; Krischer JP; Trapnell BC; ;
N Engl J Med; 2011 Apr; 364(17):1595-606. PubMed ID: 21410393
[TBL] [Abstract][Full Text] [Related]
17. [Single-breath and rebreathing methods for measurement of pulmonary diffusing function: a comparative study].
Liu QX; Zheng JP; Xie YQ; Guan WJ; Jiang CY; An JY; Yu XX; Liu WT; Gao Y
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Jul; 36(7):510-5. PubMed ID: 24262087
[TBL] [Abstract][Full Text] [Related]
18. Clinical course and characterisation of lymphangioleiomyomatosis in a Brazilian reference centre.
Baldi BG; Freitas CS; Araujo MS; Dias OM; Pereira DA; Pimenta SP; Kairalla RA; Carvalho CR
Sarcoidosis Vasc Diffuse Lung Dis; 2014 Jul; 31(2):129-35. PubMed ID: 25078640
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin-converting enzyme inhibitors may affect pulmonary function in lymphangioleiomyomatosis.
Steagall WK; Stylianou M; Pacheco-Rodriguez G; Moss J
JCI Insight; 2019 Mar; 4(5):. PubMed ID: 30843885
[TBL] [Abstract][Full Text] [Related]
20. Effects of sirolimus in lymphangioleiomyomatosis patients on lung cysts and pulmonary function: long-term follow-up observational study.
Kim C; Do KH; Cha J; Song JW; Lee SM; Lee KY
Eur Radiol; 2020 Feb; 30(2):735-743. PubMed ID: 31471750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
